Du Jinxin, Yang Meina, Zhang Zhongwen, Cao Baorui, Wang Zhiying, Han Jinxiang
Shandong University of Traditional Chinese Medicine, Jinan, China.
NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), Biomedical Sciences College, Shandong First Medical University, Jinan, China.
Front Pharmacol. 2022 Nov 14;13:1032208. doi: 10.3389/fphar.2022.1032208. eCollection 2022.
The treatment of diabetic kidney disease (DKD) has been the key concern of the medical community. Herbal medicine has been reported to alleviate intestinal dysbiosis, promote the excretion of toxic metabolites, and reduce the secretion of uremic toxins. However, the current understanding of the modulation of the gut microbiota by herbal medicine to delay the progression of DKD is still insufficient. Consequently, we reviewed the knowledge based on peer-reviewed English-language journals regarding regulating gut microbiota by herbal medicines in DKD. It was found that herbal medicine or their natural extracts may have the following effects: modulating the composition of intestinal flora, particularly , , and , as well as adjusting the F/B ratio; increasing the production of SCFAs and restoring the intestinal barrier; reducing the concentration of uremic toxins (p-cresol sulfate, indole sulfate, TMAO); inhibiting inflammation and oxidative stress.
糖尿病肾病(DKD)的治疗一直是医学界关注的重点。据报道,草药可缓解肠道菌群失调,促进有毒代谢产物的排泄,并减少尿毒症毒素的分泌。然而,目前对于草药调节肠道微生物群以延缓DKD进展的认识仍不充分。因此,我们基于同行评审的英文期刊,综述了关于草药调节DKD患者肠道微生物群的相关知识。结果发现,草药或其天然提取物可能具有以下作用:调节肠道菌群的组成,特别是[此处原文缺失具体菌群名称]、[此处原文缺失具体菌群名称]和[此处原文缺失具体菌群名称],以及调整F/B比值;增加短链脂肪酸的产生并恢复肠道屏障;降低尿毒症毒素(对甲酚硫酸盐、吲哚硫酸盐、氧化三甲胺)的浓度;抑制炎症和氧化应激。